{"downloaded": true, "htmlmade": false, "full": {"id": "26942228", "source": "MED", "pmid": "26942228", "pmcid": "PMC4772657", "fullTextIdList": {"fullTextId": "PMC4772657"}, "doi": "10.13188/2376-922x.1000010", "title": "Alternative Splicing in Alzheimer's Disease.", "authorString": "Love JE, Hayden EJ, Rohn TT.", "authorList": {"author": [{"fullName": "Love JE", "firstName": "Julia E", "lastName": "Love", "initials": "JE", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Biological Sciences, Science Building, Boise State University, USA."}}}, {"fullName": "Hayden EJ", "firstName": "Eric J", "lastName": "Hayden", "initials": "EJ", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Biological Sciences, Science Building, Boise State University, USA."}}}, {"fullName": "Rohn TT", "firstName": "Troy T", "lastName": "Rohn", "initials": "TT", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Biological Sciences, Science Building, Boise State University, USA."}}}]}, "dataLinksTagsList": {"dataLinkstag": "altmetrics"}, "journalInfo": {"issue": "2", "volume": "2", "journalIssueId": "2381010", "dateOfPublication": "2015 Aug", "monthOfPublication": "8", "yearOfPublication": "2015", "printPublicationDate": "2015-08-01", "journal": {"title": "Journal of Parkinson's disease and Alzheimer's disease", "ISOAbbreviation": "J Parkinsons Dis Alzheimers Dis", "medlineAbbreviation": "J Parkinsons Dis Alzheimers Dis", "NLMid": "101645837", "ISSN": "2376-922X", "ESSN": "2376-922X"}}, "pubYear": "2015", "abstractText": "Neurodegenerative diseases have a variety of different genes contributing to their underlying pathology. Unfortunately, for many of these diseases it is not clear how changes in gene expression affect pathology. Transcriptome analysis of neurodegenerative diseases using ribonucleic acid sequencing (RNA Seq) and real time quantitative polymerase chain reaction (RT-qPCR) provides for a platform to allow investigators to determine the contribution of various genes to the disease phenotype. In Alzheimer's disease (AD) there are several candidate genes reported that may be associated with the underlying pathology and are, in addition, alternatively spliced. Thus, AD is an ideal disease to examine how alternative splicing may affect pathology. In this context, genes of particular interest to AD pathology include the amyloid precursor protein (<i>APP</i>), <i>TAU</i>, and apolipoprotein E (<i>APOE</i>). Here, we review the evidence of alternative splicing of these genes in normal and AD patients, and recent therapeutic approaches to control splicing.", "affiliation": "Department of Biological Sciences, Science Building, Boise State University, USA.", "publicationStatus": "ppublish", "language": "eng", "pubModel": "Print-Electronic", "pubTypeList": {"pubType": ["research-article", "Journal Article"]}, "grantsList": {"grant": {"grantId": "R15 AG042781", "agency": "NIA NIH HHS", "acronym": "AG", "orderIn": "0"}}, "keywordList": {"keyword": ["Antisense oligonucleotides", "Alternative splicing", "Tau", "Alzheimer\u2019s disease", "Amyloid Precursor Protein", "Rna Sequencing", "Apo Lipoprotein E4"]}, "fullTextUrlList": {"fullTextUrl": [{"availability": "Subscription required", "availabilityCode": "S", "documentStyle": "doi", "site": "DOI", "url": "https://doi.org/10.13188/2376-922X.1000010"}, {"availability": "Open access", "availabilityCode": "OA", "documentStyle": "html", "site": "Europe_PMC", "url": "https://europepmc.org/articles/PMC4772657"}, {"availability": "Open access", "availabilityCode": "OA", "documentStyle": "pdf", "site": "Europe_PMC", "url": "https://europepmc.org/articles/PMC4772657?pdf=render"}]}, "isOpenAccess": "Y", "inEPMC": "Y", "inPMC": "N", "hasPDF": "Y", "hasBook": "N", "hasSuppl": "N", "citedByCount": "13", "hasData": "N", "hasReferences": "Y", "hasTextMinedTerms": "Y", "hasDbCrossReferences": "N", "hasLabsLinks": "Y", "license": "cc by", "authMan": "Y", "epmcAuthMan": "N", "nihAuthMan": "Y", "manuscriptId": "NIHMS721348", "hasTMAccessionNumbers": "N", "dateOfCreation": "2016-03-05", "firstIndexDate": "2016-03-05", "fullTextReceivedDate": "2020-10-21", "dateOfRevision": "2020-09-29", "electronicPublicationDate": "2015-08-15", "firstPublicationDate": "2015-08-15"}, "htmllinks": "https://europepmc.org/articles/PMC4772657", "abstract": "Neurodegenerative diseases have a variety of different genes contributing to their underlying pathology. Unfortunately, for many of these diseases it is not clear how changes in gene expression affect pathology. Transcriptome analysis of neurodegenerative diseases using ribonucleic acid sequencing (RNA Seq) and real time quantitative polymerase chain reaction (RT-qPCR) provides for a platform to allow investigators to determine the contribution of various genes to the disease phenotype. In Alzheimer's disease (AD) there are several candidate genes reported that may be associated with the underlying pathology and are, in addition, alternatively spliced. Thus, AD is an ideal disease to examine how alternative splicing may affect pathology. In this context, genes of particular interest to AD pathology include the amyloid precursor protein (<i>APP</i>), <i>TAU</i>, and apolipoprotein E (<i>APOE</i>). Here, we review the evidence of alternative splicing of these genes in normal and AD patients, and recent therapeutic approaches to control splicing.", "Keywords": ["Antisense oligonucleotides", "Alternative splicing", "Tau", "Alzheimer\u2019s disease", "Amyloid Precursor Protein", "Rna Sequencing", "Apo Lipoprotein E4"], "pdflinks": "https://europepmc.org/articles/PMC4772657?pdf=render", "journaltitle": "Journal of Parkinson's disease and Alzheimer's disease", "authorinfo": ["Love JE", "Hayden EJ", "Rohn TT"], "title": "Alternative Splicing in Alzheimer's Disease."}